Main > A1. CORP. INDEX. In-Iz > Isis Pharmaceuticals/P > 2005. 05.30.2005. (Pfizer Deal)

---

Pfizer and Isis Pharmaceuticals are collaborating to develop antisense drugs for ophthalmic disease. Isis is slated to receive a technology access fee of $1 million, research funding, and milestone payments.



2005. 05.30.2005. (Pfizer Deal)'s products
This section has no products